Cardiological aging in SAM model: Effect of chronic treatment with growth hormone

Biogerontology

Volumn 11, Issue 3, 2010, Pages 275-286

  Forman, K ^a   Vara, E ^a   Garcia C ^a   Ariznavarreta, C ^a   Escames, G ^b   Tresguerres, J A F ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Aging; Apoptosis; Cardiovascular system; Growth hormone; Inflammation; Oxidative stress

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GROWTH HORMONE; HEME OXYGENASE 1; HEME OXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEART PROTECTION; INFLAMMATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE ACCELERATED MOUSE;

AGING; ANIMALS; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; GROWTH HORMONE; HEART; MALE; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954814492     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-009-9245-z     Document Type: Article

References (54)

1. Aggarwal B (2000) Apoptosis and nuclear factor-kB: a tale of association and dissociation. Biochem Pharmacol 60:1033-1039
2. Angelopoulos TJ, Seip RL, Cole TG (1998) Effect of shortterm recombinant GH administration on plasma lipoproteins in elderly adults. Gerontology 44:228-231
3. Ariznavarreta C, Castillo C, Segovia G et al (2003) Growth hormone and aging. Homo 54(2):132-141
4. Azcoitia I, Perez-Martin M, Salazar V et al (2005) Growth hormone prevents neuronal loss in the aged rat hippocampus. Neurobiol Aging 26:697-703
5. Baeza I, Alvarado C, Ariznavarreta C et al (2008) Effect of growth hormone treatment on lymphocyte functions in old male rats. Neuroimmunomodulation 15(4-6):279-284
6. Berenson GS, Srnivasan RS (2005) Cardiovascular risk factors in youth with implications for aging: the Bogalusa heart study. Neurobiol Aging 26:303-307
7. Blackwell KA, Sorenson JP, Richardson DM et al (2004) Mechanisms of aging-induced impairment of endothelium dependent relaxation: role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 287:H2448-H2453
8. Brown-Borg HM, Rakoczy SG (2003) Growth hormone administration to long-living dwarf mice alters multiple components of the antioxidative defense system. Mech Ageing Dev 124:1013-1024
9. Brown-Borg HM, Rakoczy SG, Romanick MA et al (2002) Effects of growth hormone and insulin like growth factor- 1 on hepatocytes. Exp Biol Med 227(2):94-104
10. Brüne B, von Knethen A, Sandau KB (1998) Nitric oxide and its role in apoptosis. Eur J Pharmacol 351(3):261-272
11. Butterfield DA, Poon HF (2005) The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp Gerontol 40:774-783
12. Butterfield DA, Howard BJ, Yatin S et al (1997) Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci USA 94(2):674-678
13. Carp RI, Meeker HC, Chung R et al (2002) Murine leukemia virus in organs of senescence-prone and -resistant mouse strains. Mech Ageing Dev 123:575-584
14. Castillo C, Cruzado M, Ariznavarreta C et al (2003) Body composition and vascular effects of growth hormone administration in old female rats. Exp Gerontol 38: 971-979
15. Castillo C, Salazar V, Ariznavarreta C et al (2004) Effects of recombinant human growth hormone on age related hepatocyte changes in old male and female wistar rats. Endocrine 25(1):33-39
16. Castillo C, Cruzado M, Ariznavarreta C et al (2005a) Effects of ovariectomy and growth hormone administration on body composition and vascular function and structure and in old female rats. Biogerontology 6:49-60 (Pubitemid 41583292)
17. Castillo C, Cruzado M, Ariznavarreta C et al (2005b) Effect of recombinant growth hormone administration on body composition and vascular function and structure in old male wistar rats. Biogerontology 6:303-312 (Pubitemid 43193660)
18. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156-159
19. Chung HY, Kim HJ, Kim JW et al (2001) The inflammation hypothesis of aging molecular modulation by calorie restriction. Ann N Y Acad Sci 928:327-335
20. Chung HY, Kim HJ, Kim KW et al (2002) Molecular inflammation hypothesis of aging based on the anti- aging mechanism of calorie restriction. Microsc Res Tech 59:264-272
21. Csiszar A, Wang M, Lakatta E et al (2008) Inflammation and endothelial dysfunction during aging: role of NF-Kb. J Appl Physiol 105:1333-1341
22. Cuttica CM, Castoldi L, Gorrini GP et al (1997) Effects of sixmonth administration of rhGH to healthy elderly subjects. Aging 9:193-197
23. De la Fuente M, Baeza I, Guayerbas N et al (2004) Changes with ageing in several leukocyte functions of male and female rats. Biogerontology 5(6):389-400
24. Deijen JB, de Boer H, van der Veen EA (1998) Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 23:45-55
25. Escames G, Acuña-Castroviejo D, López LD (2006) Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol 58(9):1153-1165
26. Evans LM, Davies JS, Anderson RA et al (2000) The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 142:254-262
27. Fenton M, Huang H-L, Hong Y et al (2004) Early atherogenesis in senescence-accelerated mice. Exp Gerontol 39:115-122
28. Ferrari AU, Radaelli A, Centola M (2003) Aging and the cardiovascular system. J Appl Physiol 95:2591-2597
29. Florini JR, Roberts SD (1980) Effect of rat age on blood levels of somatomedin-like growth factors. J Gerontol 35:23-30
30. Gil P, Fariñas F, Casado A et al (2002) Malondialdehyde: a possible marker of ageing. Gerontology 48:209-214
31. Gustafsson AB, Gottlieb RA (2003) Mechanisms of apoptosis in the heart. J Clin Immunol 23(6):447-459
32. Gustafsson AB, Gottlieb RA (2007) Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 292(1):C45-C51
33. Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11:298-300
34. Hayashi M, Shimohira M, Saisho S et al (1992) Sleep disturbance in children with growth hormone deficiency. Brain Dev 14:170-174
35. Hosokawa M (2002) A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice. Mech Ageing Dev 123:1553-1561
36. Irving RJ, Carson MN, Weeb DJ (2002) Peripheral vascular structure and function in men with contrasting GH levels. J Clin Endocrinol Metab 87:3309-3314
37. Kannan K, Jain SK (2000) Oxidative stress and apoptosis. Pathophysiology 7(3):153-163
38. Kireev RA, Tresguerres ACF, Castillo C et al (2007a) Effect of exogenous administration of melatonin and growth hormone on pro-antioxidant functions of the liver in aging male rats. J Pineal Res 42:64-70
39. Kireev RA, Tresguerres AF, Vara E et al (2007b) Effect of chronic treatments with GH, melatonin, estrogens, and phytoestrogens on oxidative stress parameters in liver from aged female rats. Biogerontology 8(5):469-482
40. Kumar D, Jugdutt BI (2003) Apoptosis and oxidants in the heart. J Lab Clin Med 142(5):288-297
41. Kunz J (2000) Initial lesions of vascular aging disease (arteriosclerosis). Gerontology 46:295-299
42. Kurokawa T, Osaki N, Ishibashi S (1998) Difference between senescence-accelerated prone and resistant mice in response to insulin in the heart. Mech Ageing Dev 102:25-32
43. Lakatta E (2002) Cardiovascular ageing in health sets the stage for cardiovascular disease. Heart Lung Circ 11:76-91
44. Li S, Du M, Dolence EK et al (2005) Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification. Aging Cell 4:57-64
45. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT. Methods 25:402-408
46. Lloréns S, de Mera RM, Pascual A et al (2007) The senescence- accelerated mouse (SAM-P8) as a model for the study of vascular functional alterations during aging. Biogerontology 8:663-672
47. Maeso R, de las Heras N, Navarro-Cid J (1999) Alteraciones endoteliales en el envejecimiento. Nefrología XIX(Suppl 1): S35-S45
48. Matsugo S, Kitagawa T, Minami S et al (2000) Age-dependent changes in lipid peroxide levels in peripheral organs, but not in brain, in senescence-accelerated mice. Neurosci Lett 278:105-108
49. Matz RL, Scott C, Stoclet C et al (2000) Age related endothelial dysfunction with respect to nitric oxide, endothelium- derived hyperpolarizing factor and cyclooxygenase products. Physiol Res 49:11-18
50. McCallum RW, Petrie JR, Dominiczak AF et al (2002) Growth hormone deficiency and vascular risk. Clin Endocrinol 57:11-24
51. Nass R, Johannsson G, Christiansen JS et al (2009) The aging population-is there a role for endocrine interventions? Growth Horm IGF Res 19(2):89-100
52. Park JW, Choi CH, Kim MS et al (1996) Oxidative status in senescence-accelerated mice. J Gerontol A 51(5):B337-B345
53. Pfeifer M, Verhovec R, Zizek B et al (1999) Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 84:453-457
54. Pfeilschifter J, Köditz R, Pfohl M et al (2002) Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23:90-119